TYLE PRAVEEN 4
4 · Skye Bioscience, Inc. · Filed Jul 26, 2021
Insider Transaction Report
Form 4
TYLE PRAVEEN
Director
Transactions
- Award
Director Option Grant (Right to Buy)
2021-07-22+250,000→ 250,000 totalExercise: $0.14Exp: 2031-07-22→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Each of the Options shall be exercisable for a price of $0.14 per Option Share for ten years from July 22, 2021 (the "Grant Date") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over two years.